Exagen's market cap is currently ―. The company's EPS TTM is $-1.341; its P/E ratio is -1.16; Exagen is scheduled to report earnings on May 13, 2024, and the estimated EPS forecast is $-0.36. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 13.42M	$ 14.14M	$ 11.23M	$ 11.48M	$ 14.73M
Gross Profit	$ 7.71M	$ 8.30M	$ 5.30M	$ 5.17M	$ 8.72M
EBIT	$ -4.86M	$ -4.44M	$ -7.05M	$ -16.20M	$ -7.48M
EBITDA	$ -4.21M	$ -3.90M	$ -6.46M	$ -15.63M	$ -7.04M
Net Income Common Stockholders	$ -5.42M	$ -5.01M	$ -7.69M	$ -15.71M	$ -8.10M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 28.45M	$ 31.47M	$ 52.18M	$ 62.39M	$ 68.70M
Total Assets	$ 60.93M	$ 64.18M	$ 79.23M	$ 86.22M	$ 101.60M
Total Debt	$ 24.22M	$ 24.44M	$ 34.63M	$ 34.50M	$ 34.51M
Net Debt	$ -4.23M	$ -7.03M	$ -17.55M	$ -27.89M	$ -34.19M
Total Liabilities	$ 33.42M	$ 32.28M	$ 43.30M	$ 43.76M	$ 45.41M
Stockholders Equity	$ 27.50M	$ 31.93M	$ 35.95M	$ 42.46M	$ 56.19M
Cash Flow	-
Free Cash Flow	$ -2.91M	$ -10.48M	$ -10.14M	$ -6.14M	$ -7.56M
Operating Cash Flow	$ -2.91M	$ -10.15M	$ -9.75M	$ -5.73M	$ -6.68M
Investing Cash Flow	$ -2.00K	$ -322.00K	$ -396.00K	$ -406.00K	$ -879.00K
Financing Cash Flow	$ -108.00K	$ -10.24M	$ -62.00K	$ -173.00K	$ -22.00K

Currency in USD

Exagen Earnings and Revenue History

Income Statement >

Exagen Debt to Assets

Balance Sheet >

Exagen Cash Flow

Cash Flow >

Exagen Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing